Broadening the scope of multigene panel analysis for adult epilepsy patients
Epilepsia Open · 2024
DOI: 10.1002/epi4.12993 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia Open, 2024. Verfasst von Seungbok Lee und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genomic Medicine, Seoul National University Hospital, Seoul, Korea. Hauptthemen laut MEDLINE: Epilepsy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Seoul National University Hospital, Samjin Pharmaceutical, Korea Disease Control and Prevention Agency.
Abstract (Originalsprache)
Objective
Epilepsy is a suitable target for gene panel sequencing because a considerable portion of epilepsy is now explained by genetic components, especially in syndromic cases. However, previous gene panel studies on epilepsy have mostly focused on pediatric patients.
Methods
We enrolled adult epilepsy patients meeting any of the following criteria: family history of epilepsy, seizure onset age ≤ 19 years, neuronal migration disorder, and seizure freedom not achieved by dual anti‐seizure medications. We sequenced the exonic regions of 211 epilepsy genes in these patients. To confirm the pathogenicity of a novel MTOR truncating variant, we electroporated vectors with different MTOR variants into developing mouse brains.
Results
A total of 92 probands and 4 affected relatives were tested, and the proportion of intellectual disability (ID) and/or developmental disability (DD) was 21.7%. As a result, twelve probands (13.0%) had pathogenic or likely pathogenic variants in the following genes or regions: DEPDC5 , 15q12‐q13 duplication ( n = 2), SLC6A1 , SYNGAP1 , EEF1A2 , LGI1 , MTOR , KCNQ2 , MEF2C , and TSC1 ( n = 1). We confirmed the functional impact of a novel truncating mutation in the MTOR gene (c.7570C > T, p.Gln2524Ter) that disrupted neuronal migration in a mouse model. The diagnostic yield was higher in patients with ID/DD or childhood‐onset seizures. We also identified additional candidate variants in 20 patients that could be reassessed by further studies. Significance Our findings underscore the clinical utility of gene panel sequencing in adult epilepsy patients suspected of having genetic etiology, especially those with ID/DD or early‐onset seizures. Gene panel sequencing could not only lead to genetic diagnosis in a substantial portion of adult epilepsy patients but also inform more precise therapeutic decisions based on their genetic background. Plain Language Summary This study demonstrated the effectiveness of gene panel sequencing in adults with epilepsy, revealing pathogenic or likely pathogenic variants in 13.0% of patients. Higher diagnostic yields were observed in those with neurodevelopmental disorders or childhood‐onset seizures. Additionally, we have shown that expanding genetic studies into adult patients would uncover new types of pathogenic variants for epilepsy, contributing to the advancement of precision medicine for individuals with epilepsy. In conclusion, our results highlight the practical value of employing gene panel sequencing in adult epilepsy patients, particularly when genetic etiology is clinically suspected.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genomic Medicine, Seoul National University Hospital, Seoul, Korea.
- Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Children's Hospital, Seoul, Korea.
- Department of Neurology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea.
- Department of Life Sciences, Pohang University of Science and Technology (POSTECH), Pohang, Korea.
- Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea.
ORCID-Profile: Se Song Jang, Jihoon G Yoon, Kon Chu, Sang Kun Lee, Byung Chan Lim, Jangsup Moon
Förderung
- Seoul National University Hospital
- Samjin Pharmaceutical
- Korea Disease Control and Prevention Agency
Zitieren
APA
Lee, S., Kang, M. K., So, K. H., Jang, R., Shin, Y. W., Jang, S. S., Yoon, J. G., Kim, S., Kim, M., Chu, K., Lee, S. K., Kim, K. J., Baek, S. T., Lim, B. C., & Moon, J. (2024). Broadening the scope of multigene panel analysis for adult epilepsy patients. Epilepsia Open. https://doi.org/10.1002/epi4.12993
Vancouver
Lee S, Kang MK, So KH, Jang R, Shin YW, Jang SS, et al. Broadening the scope of multigene panel analysis for adult epilepsy patients. Epilepsia Open. 2024. doi:10.1002/epi4.12993
BibTeX
@article{Lee2024,
author = {Lee, Seungbok and Kang, Mi-Kyoung and So, Ki Hurn and Jang, Riyul and Shin, Yong Woo and Jang, Se Song and Yoon, Jihoon G and Kim, Sheehyun and Kim, Manjin and Chu, Kon and Lee, Sang Kun and Kim, Ki Joong and Baek, Seung Tae and Lim, Byung Chan and Moon, Jangsup},
title = {Broadening the scope of multigene panel analysis for adult epilepsy patients},
journal = {Epilepsia Open},
year = {2024},
doi = {10.1002/epi4.12993}
}
EUVIMED